Nonetheless, due to MATT’s low cytotoxicity against cancer cells (Supplementary Fig. S1), its antitumor activity, even when efficiently delivered to the tumor, is modest compared with that of a robust cytotoxic agent such as paclitaxel.30 The gene discussed is TMEM79; the disease is cancer.